Thus, TIM-3 may serve as a potential biomarker correlated with tumor stage, histological subtype, menopausal status, FIGO stage, and body mass index (BMI) across the spectrum of ovarian cancer cases. Here, HAVCR2 is linked to ovarian carcinoma.